BioLife Solutions presents investor update on cell-based therapy solutions
BioLife Solutions released a June 2026 investor presentation outlining its industry-leading solutions for cell-based therapies. The presentation includes financial metrics, non-GAAP measures, and forward-looking statements regarding company operations and market positioning.
View filing at SEC.gov →